Medicine

A Secret About Drug Development

People watching pharma companies and the drug development process (this includes investors/VCs, academia and the general public) from the outside will seldom think about this unmet need. The Problem If you’re a scientist, you don’t participate in the upside but you participate a lot in the downside in the case a drug fails to make it past trials and onto the market.. This isn’t exactly a secret (see interview: Vivek Ramaswamy, Roivant Sciences CEO), but is something casual biology enthusiasts or scientists in academia may not appreciate.

A Secret About Drug Development

People watching pharma companies and the drug development process (this includes investors/VCs, academia and the general public) from the outside will seldom think about this unmet need. The Problem If you’re a scientist, you don’t participate in the upside but you participate a lot in the downside in the case a drug fails to make it past trials and onto the market.. This isn’t exactly a secret (see interview: Vivek Ramaswamy, Roivant Sciences CEO), but is something casual biology enthusiasts or scientists in academia may not appreciate.

Speech Analysis

Unmet needs in areas requiring machine learning Stroke The number 1 loss of ability to speech in adults is stroke. A stroke happens roughly every 45 seconds across all people in the world. A stroke is a focal lesion, which can hit in any area of the brain. When it hits Broca’s area (responsible for speech production) or Wernicke’s area (responsible for speech formulation), speech is impaired. Autism A major shortfall of speech language therapists is in assessing and helping patents with autism.